Mirum Pharmaceuticals Inc (MIRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 99,414 | 90,377 | 77,875 | 69,222 | 69,554 |
| Cost of Goods | 22,780 | 20,806 | 20,227 | 17,830 | 25,020 |
| Gross Profit | 76,634 | 69,571 | 57,648 | 51,392 | 44,534 |
| Operating Expenses | 101,636 | 83,061 | 82,107 | 78,690 | 77,139 |
| Operating Income | -24,222 | -12,684 | -24,232 | -26,468 | -32,585 |
| Interest Expense | 3,579 | 3,586 | 3,569 | 3,577 | 3,563 |
| Other Income | 3,435 | 2,382 | 3,798 | 5,390 | 714 |
| Pre-tax Income | -24,366 | -13,888 | -24,003 | -24,655 | -35,434 |
| Income Tax | -576 | 347 | 635 | 624 | 225 |
| Net Income Continuous | -23,790 | -14,235 | -24,638 | -25,279 | -35,659 |
| Net Income | $-23,790 | $-14,235 | $-24,638 | $-25,279 | $-35,659 |
| EPS Basic Total Ops | -0.49 | -0.30 | -0.52 | -0.54 | -0.69 |
| EPS Basic Continuous Ops | -0.49 | -0.30 | -0.52 | -0.54 | -0.68 |
| EPS Diluted Total Ops | -0.49 | -0.30 | -0.52 | -0.54 | -0.69 |
| EPS Diluted Continuous Ops | -0.49 | -0.30 | -0.52 | -0.54 | -0.68 |
| EPS Diluted Before Non-Recurring Items | -0.49 | -0.30 | -0.52 | N/A | N/A |
| EBITDA(a) | $-17,750 | $-6,205 | $-17,971 | $-20,390 | $-26,692 |